UBIQUITX, INC.
Biotech · Private
Chimeric ligands for induced proximity (CLIPs), a modular platform technology for targeted posttranslational protein modification via induced proximity
- Grants
- $1.6M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Chimeric Ligands for Induced Proximity (CLIPs) for Targeted Proteome Editing | $275,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Computational design and evaluation of peptide-guided protein degraders | $306,872 | |
| Federal grant | Department of Health and Human Services · Phase I · Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing and upregulation of antigen presentation | $299,921 | |
| Federal grant | Department of Health and Human Services · Phase I · Computational design and evaluation of peptide-guided protein degraders | $6,500 | |
| Federal grant | Department of Health and Human Services · Phase I · Chimeric Ligands for Induced Proximity (CLIP) platform for targeted proteome editing to treat severe alcoholic hepatitis | $391,495 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1971 | VAST THERAPEUTICS, INC. | — | — |
| 1972 | Vesicor Therapeutics, Inc. | — | $715K |
| 1973 | FasCure Therapeutics LLC | — | — |
| 1974 | UBIQUITX, INC. | — | — |
| 1975 | ACCUNOVO BIOTECHNOLOGIES INC | — | — |
| 1976 | VLP THERAPEUTICS, INC. | — | — |
| 1977 | CILA THERAPEUTIC INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.